DLK Investment Management »

Black Diamond Therapeutics shares owned by DLK Investment Management

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by DLK Investment Management from 13F filings

Historical chart of DLK Investment Management investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by DLK Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by DLK Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $82k 16k 5.07
2023-12-31 $46k 16k 2.81